ORIGINAL ARTICLE   

Italian Journal of Dermatology and Venereology 2022 February;157(1):47-54

DOI: 10.23736/S2784-8671.21.07100-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Are irisin levels associated with inflammation and insulin resistance in patients with moderate-to-severe psoriasis?

Tugba OZKOK AKBULUT ¹ ✉, Evrim CAKIR ², Senay AGIRGOL ¹, Esma YUCETAS ³, Filiz TOPALOGLU DEMIR ¹, Ayse N. TUFAN ⁴, Zafer TURKOGLU ¹

¹ Department of Dermatology, Haseki Training and Research Hospital, Istanbul, Turkey; ² Department of Endocrinology and Metabolic Diseases, Haseki Training and Research Hospital, Istanbul, Turkey; ³ Department of Biochemistry Clinic, Haseki Training and Research Hospital, Istanbul, Turkey; ⁴ Department of Rheumatology, Haseki Training and Research Hospital, Istanbul, Turkey

BACKGROUND: A wide variety of effects of irisin, as a myokine and adipokine, have been reported. Although there are some clues about its role in the modulation of immune response in the pathogenesis of immune-mediated diseases such as psoriasis, it has not yet been clearly elucidated. The aim of the present study is to investigate the relationship of irisin levels with inflammation and insulin resistance in patients with psoriasis.
METHODS: This study was conducted in patients with moderate-to-severe psoriasis and healthy subjects who were admitted to Haseki Training and Research Hospital. In addition to routine laboratory analyses, hs-CRP, insulin, irisin, adiponectin, and leptin levels were measured. The association between irisin levels and study variables was assessed using univariate and multivariate analyses.
RESULTS: A total of 42 non-diabetic patients with moderate-to-severe psoriasis and 43 healthy subjects were enrolled. The mean irisin, waist circumference, insulin, insulin resistance, and hs-CRP, and frequency of metabolic syndrome were significantly higher in psoriasis patients than healthy controls. Psoriasis and control groups were similar in terms of adiponectin, leptin, and Body Mass Index levels. Also, hs-CRP levels were positively and strongly correlated with irisin, adiponectin, and leptin levels. The median irisin level was 2.15 µg/mL. In the binary logistic regression analysis, CRP level (OR=1.14, 95% CI 1.005-1.29, P=0.042) and a BMI>30 kg/m2 (OR=5.9, 95% CI 1.02-34.4, P=0.048) were independent predictors of a higher irisin level.
CONCLUSIONS: This study demonstrates that serum irisin levels are higher in patients with moderate-to-severe psoriasis than in healthy subjects. Irisin seems to be associated with inflammation, as measured by hs-CRP. More comprehensive studies are needed to clarify the effect of irisin, on immune-modulate response in patients with psoriasis.

KEY WORDS: Inflammation; Insulin resistance; Psoriasis